BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fleisher AS, Esteller M, Tamura G, Rashid A, Stine OC, Yin J, Zou TT, Abraham JM, Kong D, Nishizuka S. Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene. 2001;20:329-335. [PMID: 11313962 DOI: 10.1038/sj.onc.1204104] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Gray SE, Kay EW, Leader M, Mabruk MJ. Enhanced detection of microsatellite instability and mismatch repair gene expression in cutaneous squamous cell carcinomas. Mol Diagn Ther 2006;10:327-34. [PMID: 17022696 DOI: 10.1007/BF03256208] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Kulis M, Esteller M. DNA methylation and cancer. Adv Genet. 2010;70:27-56. [PMID: 20920744 DOI: 10.1016/b978-0-12-380866-0.60002-2] [Cited by in Crossref: 678] [Cited by in F6Publishing: 436] [Article Influence: 56.5] [Reference Citation Analysis]
3 Stutes M, Tran S, DeMorrow S. Genetic and epigenetic changes associated with cholangiocarcinoma: From DNA methylation to microRNAs. World J Gastroenterol 2007; 13(48): 6465-6469 [PMID: 18161915 DOI: 10.3748/wjg.v13.i48.6465] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 12] [Article Influence: 0.1] [Reference Citation Analysis]
4 Guo HH, Loeb LA. Tumbling down a different pathway to genetic instability. J Clin Invest 2003;112:1793-5. [PMID: 14679175 DOI: 10.1172/JCI20502] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
5 Carvalho B, Pinto M, Cirnes L, Oliveira C, Machado JC, Suriano G, Hamelin R, Carneiro F, Seruca R. Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas. Eur J Cancer. 2003;39:1222-1227. [PMID: 12763209 DOI: 10.1016/s0959-8049(03)00177-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
6 Yuza K, Nagahashi M, Watanabe S, Takabe K, Wakai T. Hypermutation and microsatellite instability in gastrointestinal cancers. Oncotarget 2017;8:112103-15. [PMID: 29340115 DOI: 10.18632/oncotarget.22783] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 7.4] [Reference Citation Analysis]
7 Liu P, Zhang XY, Shao Y, Zhao ZQ. Microsatellite instability in dysplasia mucosa and gastric cancer. Shijie Huaren Xiaohua Zazhi 2004; 12(3): 512-515 [DOI: 10.11569/wcjd.v12.i3.512] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Harada H, Nie Y, Araki I, Soeno T, Chuman M, Washio M, Sakuraya M, Ushiku H, Niihara M, Hosoda K, Kumamoto Y, Naitoh T, Sangai T, Hiki N, Yamashita K. Haploinsufficiency by minute MutL homolog 1 promoter DNA methylation may represent unique phenotypes of microsatellite instability-gastric carcinogenesis. PLoS One 2021;16:e0260303. [PMID: 34936649 DOI: 10.1371/journal.pone.0260303] [Reference Citation Analysis]
9 Abdelfatah E, Kerner Z, Nanda N, Ahuja N. Epigenetic therapy in gastrointestinal cancer: the right combination. Therap Adv Gastroenterol. 2016;9:560-579. [PMID: 27366224 DOI: 10.1177/1756283x16644247] [Cited by in Crossref: 62] [Cited by in F6Publishing: 24] [Article Influence: 10.3] [Reference Citation Analysis]
10 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(4): 965-968 [DOI: 10.11569/wcjd.v12.i4.965] [Reference Citation Analysis]
11 Velho S, Corso G, Oliveíra C, Seruca R. KRAS signaling pathway alterations in microsatellite unstable gastrointestinal cancers. Adv Cancer Res. 2010;109:123-143. [PMID: 21070916 DOI: 10.1016/b978-0-12-380890-5.00004-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
12 Abraham SC, Park SJ, Lee JH, Mugartegui L, Wu TT. Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes. Mod Pathol. 2003;16:786-795. [PMID: 12920223 DOI: 10.1097/01.mp.0000080349.37658.5e] [Cited by in Crossref: 74] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
13 Meyers M, Hwang A, Wagner MW, Boothman DA. Role of DNA mismatch repair in apoptotic responses to therapeutic agents. Environ Mol Mutagen 2004;44:249-64. [PMID: 15468331 DOI: 10.1002/em.20056] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
14 Pinto C, Veiga I, Pinheiro M, Mesquita B, Jeronimo C, Sousa O, Fragoso M, Santos L, Moreira-Dias L, Baptista M, Lopes C, Castedo S, Teixeira MR. MSH6 germline mutations in early-onset colorectal cancer patients without family history of the disease. Br J Cancer 2006;95:752-6. [PMID: 16940983 DOI: 10.1038/sj.bjc.6603318] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
15 Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet 2021:S0168-9525(21)00130-X. [PMID: 34120771 DOI: 10.1016/j.tig.2021.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Maroni L, Pierantonelli I, Banales JM, Benedetti A, Marzioni M. The significance of genetics for cholangiocarcinoma development. Ann Transl Med 2013;1:28. [PMID: 25332972 DOI: 10.3978/j.issn.2305-5839.2012.10.04] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
17 Moghbeli M, Moaven O, Memar B, Raziei HR, Aarabi A, Dadkhah E, Forghanifard MM, Manzari F, Abbaszadegan MR. Role of hMLH1 and E-cadherin promoter methylation in gastric cancer progression. J Gastrointest Cancer. 2014;45:40-47. [PMID: 24022108 DOI: 10.1007/s12029-013-9548-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
18 Liu L, Cao L, Gong B, Yu J. Novel biomarkers for the identification and targeted therapy of gastric cancer. Expert Rev Gastroenterol Hepatol 2015;9:1217-26. [PMID: 26220043 DOI: 10.1586/17474124.2015.1072466] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
19 Pan XM, Yang WZ, Xu GH, Bai P, Qin HJ, Zhang LS, Zhai XD, Tang M, Deng W, Zhang L, Gao LB. The association between MLH1 -93 G>A polymorphism of DNA mismatch repair and cancer susceptibility: a meta-analysis. Mutagenesis 2011;26:667-73. [PMID: 21745804 DOI: 10.1093/mutage/ger032] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ballestar E, Esteller M. Epigenetic gene regulation in cancer. Adv Genet 2008;61:247-67. [PMID: 18282509 DOI: 10.1016/S0065-2660(07)00009-0] [Cited by in Crossref: 63] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
21 Müller HM, Widschwendter M. Methylated DNA as a possible screening marker for neoplastic disease in several body fluids. Expert Rev Mol Diagn 2003;3:443-58. [PMID: 12877384 DOI: 10.1586/14737159.3.4.443] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
22 Christmann M, Kaina B. Epigenetic regulation of DNA repair genes and implications for tumor therapy. Mutat Res Rev Mutat Res 2019;780:15-28. [PMID: 31395346 DOI: 10.1016/j.mrrev.2017.10.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
23 Dauksa A, Gulbinas A, Barauskas G, Pundzius J, Oldenburg J, El-Maarri O. Whole blood DNA aberrant methylation in pancreatic adenocarcinoma shows association with the course of the disease: a pilot study. PLoS One. 2012;7:e37509. [PMID: 22629410 DOI: 10.1371/journal.pone.0037509] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
24 Anderson GR, Stoler DL, Brenner BM. Cancer: the evolved consequence of a destabilized genome. Bioessays 2001;23:1037-46. [PMID: 11746220 DOI: 10.1002/bies.1149] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
25 Bodey B, Bodey B Jr, Siegel SE. Mechanisms and markers of carcinogenesis and neoplastic progression. Expert Opin Biol Ther 2005;5:1317-32. [PMID: 16197337 DOI: 10.1517/14712598.5.10.1317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
26 Gologan A, Graham DY, Sepulveda AR. Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med. 2005;25:197-222. [PMID: 15749238 DOI: 10.1016/j.cll.2004.12.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
27 Sugai T, Habano W, Endoh M, Konishi Y, Akasaka R, Toyota M, Yamano H, Koeda K, Wakabayashi G, Suzuki K. Molecular analysis of gastric differentiated-type intramucosal and submucosal cancers. Int J Cancer. 2010;127:2500-2509. [PMID: 20178104 DOI: 10.1002/ijc.25271] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
28 Nan HM, Song YJ, Yun HY, Park JS, Kim H. Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer. World J Gastroenterol 2005; 11(25): 3834-3841 [PMID: 15991278 DOI: 10.3748/wjg.v11.i25.3834] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
29 Santos JC, Ribeiro ML. Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis. World J Gastroenterol 2015; 21(30): 9021-9037 [PMID: 26290630 DOI: 10.3748/wjg.v21.i30.9021] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
30 Stutes M, Tran S, DeMorrow S. Genetic and epigenetic changes associated with cholangiocarcinoma: from DNA methylation to microRNAs. World J Gastroenterol. 2007;13:6465-6469. [PMID: 18161915 DOI: 10.3748/wjg.13.6465] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
31 Sakata K, Tamura G, Endoh Y, Ohmura K, Ogata S, Motoyama T. Hypermethylation of the hMLH1 gene promoter in solitary and multiple gastric cancers with microsatellite instability. Br J Cancer. 2002;86:564-567. [PMID: 11870538 DOI: 10.1038/sj.bjc.6600076] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
32 Yamanaka S, Olaru AV, An F, Luvsanjav D, Jin Z, Agarwal R, Tomuleasa C, Popescu I, Alexandrescu S, Dima S. MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer. Dig Liver Dis. 2012;44:589-596. [PMID: 22464652 DOI: 10.1016/j.dld.2012.02.016] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
33 Liu P, Zhang XY, Shao Y, Zhang DF. Microsatellite instability in gastric cancer and pre-cancerous lesions. World J Gastroenterol 2005; 11(31): 4904-4907 [PMID: 16097069 DOI: 10.3748/wjg.v11.i31.4904] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
34 Sui H, Wang KB, Bai YX. DNA methylation and gastric cancer. Shijie Huaren Xiaohua Zazhi 2011; 19(32): 3347-3352 [DOI: 10.11569/wcjd.v19.i32.3347] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Limpaiboon T, Khaenam P, Chinnasri P, Soonklang M, Jearanaikoon P, Sripa B, Pairojkul C, Bhudhisawasdi V. Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma. Cancer Lett. 2005;217:213-219. [PMID: 15617839 DOI: 10.1016/j.canlet.2004.06.020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 69] [Article Influence: 1.5] [Reference Citation Analysis]
36 Jin Z, Tamura G, Honda T, Motoyama T. Molecular and Cellular Phenotypic Profiles of Gastric Noninvasive Neoplasia. Lab Invest 2002;82:1637-45. [DOI: 10.1097/01.lab.0000041712.58604.cc] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
37 Bacani J, Zwingerman R, Di Nicola N, Spencer S, Wegrynowski T, Mitchell K, Hay K, Redston M, Holowaty E, Huntsman D, Pollett A, Riddell R, Gallinger S. Tumor microsatellite instability in early onset gastric cancer. J Mol Diagn. 2005;7:465-477. [PMID: 16237216 DOI: 10.1016/s1525-1578(10)60577-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
38 Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002;21:5427-5440. [PMID: 12154405 DOI: 10.1038/sj.onc.1205600] [Cited by in Crossref: 775] [Cited by in F6Publishing: 708] [Article Influence: 38.8] [Reference Citation Analysis]
39 Sasaki S, Yashima K, Hayashi A, Takeda Y, Yasugi A, Koda M, Kawaguchi K, Harada K, Ito H, Murawaki Y. Clinicopathological and patient characteristics of early gastric neoplasia endoscopically resected with loss of Mlh1 expression. Oncol Lett 2011;2:217-22. [PMID: 22866067 DOI: 10.3892/ol.2010.231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
40 Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 2006; 12(2): 192-198 [PMID: 16482617 DOI: 10.3748/wjg.v12.i2.192] [Cited by in CrossRef: 146] [Cited by in F6Publishing: 145] [Article Influence: 9.1] [Reference Citation Analysis]
41 Fang DC, Wang RQ, Yang SM, Yang JM, Liu HF, Peng GY, Xiao TL, Luo YH. Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instability. World J Gastroenterol 2003; 9(4): 655-659 [PMID: 12679904 DOI: 10.3748/wjg.v9.i4.655] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 34] [Article Influence: 1.7] [Reference Citation Analysis]
42 Gao C, Zhang Q, Kong D, Wu D, Su C, Tong J, Chen F, Zhang Q. MALDI-TOF Mass Array Analysis of Nell-1 Promoter Methylation Patterns in Human Gastric Cancer. Biomed Res Int 2015;2015:136941. [PMID: 26090379 DOI: 10.1155/2015/136941] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
43 Meyers M, Hwang A, Wagner MW, Bruening AJ, Veigl ML, Sedwick WD, Boothman DA. A role for DNA mismatch repair in sensing and responding to fluoropyrimidine damage. Oncogene 2003;22:7376-88. [PMID: 14576845 DOI: 10.1038/sj.onc.1206941] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
44 Sakurai M, Zhao Y, Oki E, Kakeji Y, Oda S, Maehara Y. High-resolution fluorescent analysis of microsatellite instability in gastric cancer. Eur J Gastroenterol Hepatol 2007;19:701-9. [PMID: 17625441 DOI: 10.1097/MEG.0b013e3281ac20a8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
45 Lee JH, Park SJ, Abraham SC, Seo JS, Nam JH, Choi C, Juhng SW, Rashid A, Hamilton SR, Wu TT. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene. 2004;23:4646-4654. [PMID: 15064707 DOI: 10.1038/sj.onc.1207588] [Cited by in Crossref: 91] [Cited by in F6Publishing: 73] [Article Influence: 5.1] [Reference Citation Analysis]
46 Francis H, Alpini G, DeMorrow S. Recent advances in the regulation of cholangiocarcinoma growth. Am J Physiol Gastrointest Liver Physiol 2010;299:G1-9. [PMID: 20430870 DOI: 10.1152/ajpgi.00114.2010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 64] [Article Influence: 1.6] [Reference Citation Analysis]
47 Oda S, Zhao Y, Maehara Y. Microsatellite instability in gastrointestinal tract cancers: a brief update. Surg Today 2005;35:1005-15. [PMID: 16341479 DOI: 10.1007/s00595-005-3125-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
48 Fülöp Z, Csernus B, Tímár B, Szepesi Á, Matolcsy A. Microsatellite instability and hMLH1 promoter hypermethylation in Richter’s transformation of chronic lymphocytic leukemia. Leukemia 2003;17:411-5. [DOI: 10.1038/sj.leu.2402792] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
49 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2003; 11(1): 65-71 [DOI: 10.11569/wcjd.v11.i1.65] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
50 Kővári B, Kim BH, Lauwers GY. The pathology of gastric and duodenal polyps: current concepts. Histopathology 2021;78:106-24. [PMID: 33382489 DOI: 10.1111/his.14275] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Holmes K, Egan B, Swan N, O'Morain C. Genetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma. Curr Genomics. 2007;8:379-397. [PMID: 19412438 DOI: 10.2174/138920207783406460] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
52 Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M, Kitano S, Hirohashi S. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol. 2004;164:689-699. [PMID: 14742272 DOI: 10.1016/s0002-9440(10)63156-2] [Cited by in Crossref: 198] [Cited by in F6Publishing: 81] [Article Influence: 11.0] [Reference Citation Analysis]
53 Shi X, Li X, Chen L, Wang C. Analysis of somatostatin receptors and somatostatin promoter methylation in human gastric cancer. Oncol Lett 2013;6:1794-8. [PMID: 24260078 DOI: 10.3892/ol.2013.1614] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
54 Rodríguez-Jiménez FJ, Moreno-Manzano V, Lucas-Dominguez R, Sánchez-Puelles JM. Hypoxia causes downregulation of mismatch repair system and genomic instability in stem cells. Stem Cells 2008;26:2052-62. [PMID: 18511603 DOI: 10.1634/stemcells.2007-1016] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
55 Chaudhry P, Srinivasan R, Patel FD. Utility of gene promoter methylation in prediction of response to platinum-based chemotherapy in epithelial ovarian cancer (EOC). Cancer Invest 2009;27:877-84. [PMID: 19548140 DOI: 10.1080/07357900902849699] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
56 Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T, Miwa H, Lim KJ, Das KM. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol 2014; 20(18): 5461-5473 [PMID: 24833876 DOI: 10.3748/wjg.v20.i18.5461] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 90] [Article Influence: 12.9] [Reference Citation Analysis]
57 Shibata D, Mori Y, Cai K, Zhang L, Yin J, Elahi A, Hamelin R, Wong YF, Lo WK, Chung TK, Sato F, Karpeh MS, Meltzer SJ. RAB32 hypermethylation and microsatellite instability in gastric and endometrial adenocarcinomas. Int J Cancer 2006;119:801-6. [DOI: 10.1002/ijc.21912] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
58 Choi WS, Seo HS, Song KY, Yoon JH, Kim O, Nam SW, Lee JY, Park WS. Gastrokine 1 expression in the human gastric mucosa is closely associated with the degree of gastritis and DNA methylation. J Gastric Cancer. 2013;13:232-241. [PMID: 24511419 DOI: 10.5230/jgc.2013.13.4.232] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
59 G??m??ri ?, P??l J, M??sz??ros I, D??czi T, Matolcsy A. Epigenetic Inactivation of the hMLH1 Gene in Progression of Gliomas: . Diagnostic Molecular Pathology 2007;16:104-7. [DOI: 10.1097/pdm.0b013e318033f140] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
60 Alvarez MC, Santos JC, Maniezzo N, Ladeira MS, da Silva AL, Scaletsky IC, Pedrazzoli Jr J, Ribeiro ML. MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults. World J Gastroenterol 2013; 19(20): 3043-3051 [PMID: 23716983 DOI: 10.3748/wjg.v19.i20.3043] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
61 Coleman WB, Tsongalis GJ. Molecular mechanisms of human carcinogenesis. EXS 2006;:321-49. [PMID: 16383025 DOI: 10.1007/3-7643-7378-4_14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 0.3] [Reference Citation Analysis]
62 Yao Y, Tao H, Park DI, Sepulveda JL, Sepulveda AR. Demonstration and characterization of mutations induced by Helicobacter pylori organisms in gastric epithelial cells. Helicobacter. 2006;11:272-286. [PMID: 16882331 DOI: 10.1111/j.1523-5378.2006.00408.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
63 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2005; 13(19): 2349-2354 [DOI: 10.11569/wcjd.v13.i19.2349] [Reference Citation Analysis]
64 Freiberg RA, Hammond EM, Dorie MJ, Welford SM, Giaccia AJ. DNA damage during reoxygenation elicits a Chk2-dependent checkpoint response. Mol Cell Biol 2006;26:1598-609. [PMID: 16478982 DOI: 10.1128/MCB.26.5.1598-1609.2006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
65 Bornschein J, Weigt J, Selgrad M, Malfertheiner P. Molecular aspects in the diagnosis of gastric cancer. Expert Opin Med Diagn 2009;3:585-96. [PMID: 23495987 DOI: 10.1517/17530050902862175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
66 Pozza DH, De Mello RA, Araujo RLC, Velcheti V. MicroRNAs in Lung Cancer Oncogenesis and Tumor Suppression: How it Can Improve the Clinical Practice? Curr Genomics 2020;21:372-81. [PMID: 33093800 DOI: 10.2174/1389202921999200630144712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Suzuki H, Hirata Y, Suzuki N, Ihara S, Sakitani K, Kobayashi Y, Kinoshita H, Hayakawa Y, Yamada A, Watabe H, Tateishi K, Ikenoue T, Yamaji Y, Koike K. Characterization of a new small bowel adenocarcinoma cell line and screening of anti-cancer drug against small bowel adenocarcinoma. Am J Pathol 2015;185:550-62. [PMID: 25478808 DOI: 10.1016/j.ajpath.2014.10.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
68 Carneiro F, Oliveira C, Leite M, Seruca R. Molecular targets and biological modifiers in gastric cancer. Semin Diagn Pathol. 2008;25:274-287. [PMID: 19013893 DOI: 10.1053/j.semdp.2008.07.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
69 Singh KP, Kumari R, Dumond JW. Simulated microgravity-induced epigenetic changes in human lymphocytes. J Cell Biochem 2010;111:123-9. [PMID: 20506542 DOI: 10.1002/jcb.22674] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
70 Kawaguchi K, Yashima K, Koda M, Tsutsumi A, Kitaoka S, Andachi H, Hosoda A, Kishimoto Y, Shiota G, Ito H, Murawaki Y. Fhit expression in human gastric adenomas and intramucosal carcinomas: correlation with Mlh1 expression and gastric phenotype. Br J Cancer 2004;90:672-7. [PMID: 14760383 DOI: 10.1038/sj.bjc.6601601] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
71 Sato F, Meltzer SJ. CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer. 2006;106:483-493. [PMID: 16362978 DOI: 10.1002/cncr.21657] [Cited by in Crossref: 100] [Cited by in F6Publishing: 99] [Article Influence: 6.3] [Reference Citation Analysis]
72 Kloten V, Rose M, Kaspar S, von Stillfried S, Knüchel R, Dahl E. Epigenetic inactivation of the novel candidate tumor suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator phenotype. Epigenetics 2014;9:1290-301. [PMID: 25093535 DOI: 10.4161/epi.32089] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
73 Guo HH, Loeb LA. Tumbling down a different pathway to genetic instability. J Clin Invest 2003;112:1793-5. [DOI: 10.1172/jci200320502] [Cited by in Crossref: 25] [Article Influence: 1.3] [Reference Citation Analysis]
74 Bischoff J, Ignatov A, Semczuk A, Schwarzenau C, Ignatov T, Krebs T, Küster D, Przadka-rabaniuk D, Roessner A, Costa SD, Schneider-stock R. hMLH1 promoter hypermethylation and MSI status in human endometrial carcinomas with and without metastases. Clin Exp Metastasis 2012;29:889-900. [DOI: 10.1007/s10585-012-9478-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
75 Wu PY, Zhang Z, Wang JM, Guo WW, Xiao N, He Q, Wang YP, Fan YM. Germline promoter hypermethylation of tumor suppressor genes in gastric cancer. World J Gastroenterol 2012; 18(1): 70-78 [PMID: 22228973 DOI: 10.3748/wjg.v18.i1.70] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]